Business Description
HPC Biosciences Ltd
ISIN : INE507O01025
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.99 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 955.66 | |||||
Beneish M-Score | -2.26 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -44.2 | |||||
3-Year EPS without NRI Growth Rate | -63.2 | |||||
3-Year Book Growth Rate | 0.3 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 99.44 | |||||
Quick Ratio | 99.44 | |||||
Cash Ratio | 1.88 | |||||
Days Sales Outstanding | 10030.15 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -248.08 | |||||
Net Margin % | 10 | |||||
FCF Margin % | -164.71 | |||||
ROE % | 0.07 | |||||
ROA % | 0.07 | |||||
ROIC % | -1.23 | |||||
ROC (Joel Greenblatt) % | -6.53 | |||||
ROCE % | -1.63 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 26200 | |||||
PE Ratio without NRI | 26200 | |||||
Shiller PE Ratio | 178.91 | |||||
PS Ratio | 2015.38 | |||||
PB Ratio | 13.1 | |||||
Price-to-Tangible-Book | 13.1 | |||||
EV-to-EBIT | -796.18 | |||||
EV-to-EBITDA | -20046.02 | |||||
EV-to-Revenue | 1975.16 | |||||
EV-to-FCF | -1199.19 | |||||
Price-to-Projected-FCF | 13.37 | |||||
Price-to-Median-PS-Value | 7.82 | |||||
Price-to-Graham-Number | 124.76 | |||||
Price-to-Net-Current-Asset-Value | 16.17 | |||||
Price-to-Net-Cash | 2620 | |||||
Earnings Yield (Greenblatt) % | -0.13 | |||||
FCF Yield % | -0.08 | |||||
Forward Rate of Return (Yacktman) % | -5.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
HPC Biosciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 2.111 | ||
EPS (TTM) (₹) | 0.001 | ||
Beta | 0.02 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (₹) | 0 | ||
20-Day SMA (₹) | 26.2 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (₹) | 26.2 - 26.2 | ||
Shares Outstanding (Mil) | 159.6 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
HPC Biosciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
HPC Biosciences Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
HPC Biosciences Ltd Frequently Asked Questions
What is HPC Biosciences Ltd(BOM:535217)'s stock price today?
When is next earnings date of HPC Biosciences Ltd(BOM:535217)?
Does HPC Biosciences Ltd(BOM:535217) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |